3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Urinary Bladder Neoplasms
2
Recurrence
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Lymphoma
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anus Neoplasms
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Doxorubicin
26
pembrolizumab
24
Radiotherapy
20
Cyclophosphamide
18
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
Nivolumab
14
Gemcitabine
13
Ifosfamide
12
Surgical Procedures, Operative
11
Biopsy
11
Radiation
10
X-Rays
8
Temozolomide
8
Ipilimumab
8
pazopanib
7
fludarabine
7
cabozantinib
7
Irinotecan
7
tazemetostat
6
liposomal doxorubicin
6
Trabectedin
6
Surveys and Questionnaires
6
Phantoms, Imaging
6
Blood Specimen Collection
6
olaparib
5
eribulin
5
atezolizumab
5
anlotinib
5
Vincristine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
entinostat
×
1 year
×
Clear all
No trials found.